ロード中...
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness
BACKGROUND & AIMS: Hepatitis C virus (HCV) eradication with direct-acting antivirals (DAAs) reduces but does not eliminate the risk for hepatocellular carcinoma (HCC). The development of surveillance strategies for HCC after the sustained virologic response (SVR) is therefore warranted. We aimed...
保存先:
| 出版年: | JHEP Rep |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8165428/ https://ncbi.nlm.nih.gov/pubmed/34095798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100289 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|